Skip to main content

Principles of Cloning

  • 2nd Edition - September 24, 2013
  • Latest edition
  • Editors: Jose Cibelli, Ian Wilmut, Rudolf Jaenisch, John Gurdon, Robert Lanza, Michael West, Keith H.S. Campbell
  • Language: English

Principles of Cloning, Second Edition is the fully revised edition of the authoritative book on the science of cloning. The book presents the basic biological mechanisms of… Read more

Description

Principles of Cloning, Second Edition is the fully revised edition of the authoritative book on the science of cloning. The book presents the basic biological mechanisms of how cloning works and progresses to discuss current and potential applications in basic biology, agriculture, biotechnology, and medicine. Beginning with the history and theory behind cloning, the book goes on to examine methods of micromanipulation, nuclear transfer, genetic modification, and pregnancy and neonatal care of cloned animals. The cloning of various species—including mice, sheep, cattle, and non-mammals—is considered as well.
The Editors have been involved in a number of breakthroughs using cloning technique, including the first demonstration that cloning works in differentiated cells done by the Recipient of the 2012 Nobel Prize for Physiology or Medicine – Dr John Gurdon; the cloning of the first mammal from a somatic cell – Drs Keith Campbell and Ian Wilmut; the demonstration that cloning can reset the biological clock - Drs Michael West and Robert Lanza; the demonstration that a terminally differentiated cell can give rise to a whole new individual – Dr Rudolf Jaenisch and the cloning of the first transgenic bovine from a differentiated cell – Dr Jose Cibelli. The majority of the contributing authors are the principal investigators on each of the animal species cloned to date and are expertly qualified to present the state-of-the-art information in their respective areas.

Key features

  • First and most comprehensive book on animal cloning, 100% revised
  • Describes an in-depth analysis of current limitations of the technology and research areas to explore
  • Offers cloning applications on basic biology, agriculture, biotechnology, and medicine

Readership

Bioengineers, biochemists, cell biologists, bone biologists, and geneticists.

Table of contents

Editorial Advisory Board

Foreword to the Second Edition

References

Foreword to the First Edition

Preface to the First Edition

In remembrance of Keith Henry Stockman Campbell (23 May 1954–5 October 2012)

List of Contributors

Part I: Basics

Chapter 1. Artificial Activation of Mammalian Oocytes for Cloning: Present Status and Future Perspectives

Introduction

Egg Activation Protocols

Common Activation Procedures for Mouse Eggs

Common Activation Procedures for Bovine and Porcine Eggs

Common Activation Procedures for Human Eggs

Conclusions

Acknowledgements

References

Chapter 2. Epigenetic Reprogramming of Somatic Nuclei via Cell Fusion

Introduction

Epigenetic Reprogramming of Somatic Cells by Hybridization with Embryonic Stem Cells

Epigenetic Reprogramming of Somatic Cells by Hybridization with Embryonic Germ Cells

Role of Cell Fusion In Vivo

Cloning by Somatic Cell Transplantation into Oocytes

Molecular Mechanisms of Epigenetic Reprogramming Mediated by Cell Fusion

Conclusion

References

Chapter 3. Nuclear Origins and Clone Phenotype: What Cloning Tells Us about Embryonic Development

Introduction

Aberrant Properties of Cloned Embryos

Effects of Developmental Stage of Donor Nucleus

Effects of Cell Type of Donor Nucleus

Effects of Donor Nucleus Cell Cycle Stage

Effects of Recipient Cell Type and Stage

Effects of Genotype and Sex of Donor Nucleus

Effects of Species Origin of Donor and Recipient – Challenges of Inter-Species Nuclear Transfer

Remediation of Aberrant Properties

Mysteries yet to be Solved

Acknowledgements

References

Part II: Methods

Chapter 4. Micromanipulation Techniques for Cloning

Introduction

Making Manipulation Tools

Microscopy and Equipment for Micromanipulation

Micromanipulation Procedures

Piezoelectric Assisted Nuclear Transfer

Technical Improvements

References

Chapter 5. Nuclear Transfer with Germ Cells: Germ Cell Cloning Contributes to Current Understanding of Genomic Imprinting in Mammals

Introduction

The Absence of Genomic Imprinting in Germ Cell (GC) Embryos

Detection of Erasure Process of Genomic Imprinting in Cloned Embryos Using Day 11.5 PGCs

Establishment of Genomic Imprinting Using Gonocyte Clone Embryos

Why is a Monoallelic Expression System of Imprinted Genes from Both Parental Alleles Essential for Mammalian Development?

Perspective

Acknowledgements

References

Chapter 6. Culture of Viable Mammalian Embryos In Vitro

Introduction

Dynamics of Embryo and Maternal Physiology

Metabolism of the Embryo

Impact of Intracellular Stress to the Embryo

Development of Sequential Embryo Culture Media

Inherent Problems of Co-Culture

Send in the Clones

Conclusions

References

Chapter 7. Genetic and Phenotypic Similarity Among Members of Mammalian Clonal Sets

Introduction

Definition of Cloning

Cytoplasmic Genetics

Epigenetic Effects

Uterine Effects

Neonatal Environment

Large Offspring Syndrome

Mutations

Cultural Inheritance

How Similar?

Summary and Perspective

References

Chapter 8. Advances in the Generation of Transgenic Domestic Species via Somatic Cell Nuclear Transfer

Introduction

Methods to Generate Transgenic Animals

Methods to Generate “Loss-Of-Function” Mutations Through SCNT

Additional Considerations

References

Chapter 9. Pregnancy and Neonatal Care of SCNT Animals

Overview of Cloning Efficiency

Health and Care of SCNT Cattle

Health and Care of SCNT Pigs

Health and Care of Other Species

Conclusion

Acknowledgements

References

Chapter 10. Donor Cell Type and Cloning Efficiency in Mammals

Developmental Potential of Germline Nuclei at Various Cell Cycle Stages

Developmental Potential of Somatic Cell Line Nuclei from Different Tissues

Acknowledgement

References

Chapter 11. Enhancing SCNT with Chromatin Remodeling Agents

Introduction

Establishment of a Concept for Direct Treatment of SCNT Embryos with Chemical Agents

Discovery of the Optimal Treatment of SCNT Embryos with Trichostatin A

SCNT using HDACi Treatment

The Possible Mechanism Underlying HDACi Treatment to Enhance Reprogramming

The Targets of HDACi to Enhance Nuclear Reprogramming

Why do Cloned Embryos Require HDACi Treatment for Better Genomic Reprogramming?

Further Studies of Agents that may Improve SCNT

Concluding Remarks

References

Chapter 12. Cell Cycle Regulation in Cloning

Introduction

Initial Events

Oocyte Development and the Cell Cycle

Cell Cycle Effects of Oocyte-Derived Cytoplast Recipients

Other Factors Related to the Recipient Cell Cycle Phase

Effects of Cell Cycle Combinations on Development

Effects of the Donor Cell Cycle Stage on Development

Summary

References

Chapter 13. Clone-Specific X-Linked Gene Repression Caused by Ectopic Xist Transcripts from the Active X Chromosome

Introduction

Aberrantly Expressed Genes In Pre-Implantation-Stage SCNT Embryos

Global Gene Expression Analysis and X-Chromosome Gene Repression in Cloned Embryos

Role of Xist in Pre-Implantation Embryos

Improvement of Cloning Efficiency Using Gene Knockout (KO) and Knockdown (KD) Animals

Why is Xist Expressed Ectopically in Scnt Pre-Implantation Embryos?

Xist-Independent Non-Random Errors in Cloned Embryos

Future Perspectives

References

Part III: Cloning by Species

Chapter 14. Cloning of Amphibia

Introduction and Background

Development of Nuclear Transfer Embryos Using Second Meiotic Metaphase Eggs

Immediate Changes in Transplanted Nuclei

Mechanisms of Nuclear Reprogramming by Meiotic Prophase Oocytes

Acknowledgements

References

Chapter 15. Cloning of Medaka Fish

Introduction

Study of Cloning in Medaka

Transfer of Adult Somatic Cell Nuclei into Diploidized Eggs

Successful Generation of Adult NTs

Mechanisms Requiring Investigation

Perspective

References

Chapter 16. Somatic Cell Nuclear Transfer in Zebrafish

Introduction

The Recipient Egg

The Donor Cells

Egg Activation Following Nuclear Transfer

Cloning Efficiency in Zebrafish

Conclusion and Closing Remarks

References

Chapter 17. Cloning of Mice

Introduction

Abnormalities Found in Cloned Mice

Where Are the Genomic Reprogramming Factors?

Improving Mouse Cloning by Technical Advances

Improvement of Mouse Cloning by Finding the Best Donor Cells

Combination of ntes Cell Approaches for Mouse Cloning

A New Tool for the Study of Basic Biology

Perspectives

References

Chapter 18. Cloning of Rabbits

Introduction

Background of Rabbit Embryo Embryology

State of the Art

Applications of Somatic Cell Nuclear Transfer in Rabbits

Appendix: Protocol for Rabbit Somatic Cell Nuclear Transfer

Acknowledgements

References

Chapter 19. Cloning Pigs by Somatic Cell Nuclear Transfer

Introduction

HIstory of SCNT in Swine

Applications of Genetically Engineered Pigs Produced Through SCNT

Culture of Pig Embryos

Uniqueness of SCNT Embryos

Reprogramming of Donor Cells

Methods to Improve the Efficiency of SCNT by Altering Epigenetic Marks

The Search for the Ideal Donor Cell Type

Future Direction

Acknowledgements

References

Chapter 20. A Historical Perspective of the Cloning of Cattle

Introduction

History

Cloning from Fetal Cells

Fetal Germ Line-Derived Cells

Fetal Somatic Cells

Cloning from Adult Somatic Cells

Aggregation of NT Embryos During Culture

Telomeres

Large-Offspring Syndrome

Food Safety of Milk and Meat Products Derived from the Use of Cloned Cattle for Milk or Meat Production

References

Chapter 21. Cloning of Canines

Introduction

History of Dog Cloning

Methodology of Canine Cloning

Postnatal Characteristics of cloneD Dogs

Applications of Nuclear Transfer

Acknowledgement

References

Chapter 22. Cloning of Equines

Procedures for Cloning Equines

Application of Cloning and Final Considerations

Acknowledgements

References

Chapter 23. Cloning Primates

Introduction

Overview of SCNT in Primates

Challenges in Primate SCNT

Note

Acknowledgements

References

Part IV: Applications

Chapter 24. Nuclear Transfer for Stem Cells

Introduction

Reprogramming Pluripotentiality by Nuclear Transfer

Reprogramming Pluripotentiality Using Transcription Factors

Human Somatic Cell Nuclear Transfer – What is the Difficulty?

The Future for SCNT Embryonic Stem Cells

References

Chapter 25. Current Research and Commercial Applications of Cloning Technology

Introduction

Cloning Research Animals

Previous and Present Obstacles to Commercial Cloning in Animal Agriculture

Summary

References

Chapter 26. Transgenic Cloned Goats and the Production of Recombinant Therapeutic Proteins

Introduction

Mammary Gland-Specific Transgenes for SCNT

Early Applications of SCNT for the Generation of Transgenic Goats

Oocyte Source, Cell Source, and SCNT Parameters

Generation of Transgenic Founders by Transfected SCNT

Production of Transgenic Goats by Adult SCNT

Detail Morbidity and Mortality

Transgenically Derived Recombinant Monoclonal Antibodies

Conclusion

Acknowledgements

References

Chapter 27. Commercializing Genetically Engineered Cloned Cattle

Research and Development

Cell Banking and Founder Animals

Animal Sourcing

Production Facilities

Quality and Risk

Animal Regulatory Oversight and Compliance in the United States

Conclusions

References

Chapter 28. Cloning Endangered Species

Introduction

Improving the Reproductive Potential of Endangered Animals

Pros and Cons of Using Somatic Cell Nuclear Transfer as a Bioremediation Tool

Zygotic Genome Activation Failure

Inbreeding

The Neglected Issue: Lack of Foster Mothers for Cloned Embryos

The State of the Art of Inter-Species Somatic Cell Nuclear Transfer for Multiplying Endangered Animals

Land Preservation

Establishing Biobanks for Endangered Animals

Improving Inter-Species Somatic Cell Nuclear Transfer

Removing Immunological Barriers to Embryo Transfer: Making the “Universal” Foster Mother

Conclusions

Acknowledgements

References

Part V: Complementary Technologies

Chapter 29. Genome Editing in Somatic Cells Using Zinc Finger Nucleases and Transcription Activator-Like Effector Nucleases

Setting the Stage for Genome Editing

The Power of the DSB

Making the Cut: ZFNs and TALENs

The Process of Creating a Modified Mammalian Somatic Cell

Acknowledgement

References

Chapter 30. Targeted Chromosome Elimination from ES-Somatic Hybrid Cells

Introduction

Homologous Recombination-Based Chromosome Engineering

Site-Specific Recombination

Systems to Introduce DNA Fragments

The Need for Techniques to Delete Large DNA Fragments

Chromosome Elimination Cassette

Conclusion

References

Part VI: SCNT as a Tool to Answer Biological Questions

Chapter 31. How Cell Division Facilitates Nuclear Reprogramming

Introduction

Nuclear Factors are Required for Reprogramming

Reprogramming Factors Localize to the Cytoplasm During Meiosis and Mitosis

Reprogramming Factors are Cell Type-Specific Regulators of Gene Expression

Transcriptional Reprogramming Depends on Mitotic Remodeling of the Nuclear Structure

Cell Division Correlates with Reprogramming to Induced Pluripotent Stem Cells

Nuclear Structure is Involved in the Regulation of Cell Type-Specific Gene Expression

Reprogramming of DNA Replication

Conclusion

Acknowledgements

References

Chapter 32. Proteomic Approach to the Reprogramming Machinery of the Mouse Oocyte

Introduction

Results

Discussion

Materials and Methods

Acknowledgements

References

Chapter 33. Biological Age of Cloned Animals

Introduction

Production of Embryos Cloned from Tissues Preserved for a Short Period

Cloning Regeneration of an Elite Bull from an Organ Frozen for more than a Decade Without Cryoprotectants

Concluding Remarks

References

Chapter 34. Mitochondrial DNA: Its Transmission from Gametes and Embryos

Introduction

The Mitochondrial Genome

Oxidative Phosphorylation

Mitochondrial DNA Replication

Segregation, Transmission, and Inheritance of Mitochondrial DNA

The Control of Mitochondrial DNA Replication During Development

How do Nuclear Transfer Embryos Control These Processes?

Mixing of Mitochondrial DNA Genotypes

Why Does the Donor Cell Mitochondrial DNA Persist?

Toxicity of Somatic Mitochondrial DNA

Is There a Relationship between Donor Cell and Recipient Oocyte Mitochondrial DNA that Affects Somatic Cell Nuclear Transfer Outcome?

Conclusion

Acknowledgement

References

Chapter 35. Interspecies Somatic Cell Nuclear Transfer

Introduction

Historical Perspective of Nuclear Transplantation (NT)

Interspecies Nuclear Transfer

Conclusions

References

Chapter 36. Epigenetics of Cloned Livestock Embryos and Offspring

Introduction

DNA Methylation Profiles in Cloned Embryos and Fetuses

Imprinted Gene Expression in Cloned Embryos and Fetuses

X-Chromosome Inactivation After Somatic Cloning

Telomere Length and Somatic Cloning

Conclusions and Perspectives

References

Chapter 37. Comparing SCNT-Derived ESCs and iPSCs

Introduction

Known Differences Between SCNT-ESCs and iPSCs

Conclusions

References

Chapter 38. Role of iPSC-Producing Factors in Pre-Implantation Embryos

Introduction

Expression Patterns and Functions of Reprogramming Factors in Pre-Implantation Embryos

Conclusions

References

Part VII: Ethical and Legal Affairs

Chapter 39. Genome Exchange in Human Oocytes

Introduction

Induced Pluripotent Stem Cells or Nuclear Transfer Embryonic Stem Cells?

A Source of Oocytes for Research

Human Oocytes Contain Reprogramming Activities

Genome Transfer to Prevent the Transmission of Mitochondrial Disease

Pronuclear Transfer in Zygotes

Genome Transfer in Unfertilized Human Oocytes

Acknowledgement

References

Chapter 40. Ethical Implications of Reproductive Cloning

Introduction

Reproductive Cloning

Nightmare Scenarios

Serious Ethical Concerns

Physiological Harms to Offspring

Psychological Harms

Social Harms

References

Chapter 41. An Overview of the Regulatory Considerations for Animal Cloning

Introduction

The US Process

Scientific Findings from other Competent Bodies

Statements Regarding Cloning from Scientific and Professional Organizations

Regulatory Status

What Does the Future Hold?

Future Developments and Expectations for Additional Research

Concluding Observations

References

Author Index

Subject Index

Product details

  • Edition: 2
  • Latest edition
  • Published: October 28, 2013
  • Language: English

About the editors

JC

Jose Cibelli

Dr. Cibelli is Professor of Animal Biotechnology at Michigan State University. He heads the Cellular Reprogramming Laboratory in the Departments of Animal Science and Physiology since 2003. From 2010 to 2017 he was also the Scientific Director of LARCel, a laboratory of cellular reprogramming dedicated to generating human pluripotent cells under GMP conditions for preclinical studies in Andalucia, Spain. Dr. Cibelli is internationally recognized as one of the pioneers in the area of cellular reprogramming using oocyte-driven protocols. Dr. Cibelli together with his colleagues, were responsible for the generation of the world's first transgenic cloned calves, the first stem cells by nuclear transfer in bovine, the first embryonic stem cells by parthenogenesis in primates and the generation of the first cell line of iPSCs using oocyte factors alone. His work has been published un numerous scientific journals including Science, Nature Biotechnology, Nature Medicine, Nature Methods, PNAS, Cell Stem Cell and JAMA.
Affiliations and expertise
Cellular Reprogramming Laboratory, Michigan State University, Ann Arbor, MI, USA

IW

Ian Wilmut

Sir Ian Wilmut is an embryologist who famously led the team that successfully cloned ‘Dolly the sheep’ in the mid-1990s. To achieve this technical feat, the team established a technique for transferring nuclei from adult sheep cells to unfertilized sheep eggs that had had their own nuclei removed. He now conducts research on adult cells, using techniques that avoid the need to obtain embryonic cells. Ian’s current work aims to convert skin cells into stem cells that have the ability to form all tissues. By deriving these cells from donors who have inherited degenerative diseases, it is possible to gain new understanding of how diseases arise and search for medicines that are able to prevent the degeneration. In the long run, stem cells will be used in new treatments. Ian is a strong advocate of a proposal to develop a global network of cell banks, making it possible for anyone in the world to have access to such cell therapy.
Affiliations and expertise
Director, MRC Centre for Regenerative Medicine, Edinburgh, UK

RJ

Rudolf Jaenisch

Rudolf Jaenisch produced the first transgenic animals in the 1970. In the 80’s and 90’s his lab made many contributions to the understanding of cancer, neurological diseases, and the role of DNA methylation in mammalian development using transgenic mice. The lab was one of three labs worldwide that reported in 2007 cells taken from mouse tails could be reprogrammed into iPSCs by over-expressing four master gene regulators. Later that year, the lab followed up by further manipulating iPSCs to treat sickle-cell anemia in mice, the first proof in principle of therapeutic use of such cells. In 2008, the lab reported that neurons derived from iPSCs successfully integrated into fetal mouse brains and reduced symptoms in a Parkinson’s disease rat model. The Jaenisch Lab focuses on understanding the genetic and epigenetic basis of familial and sporadic diseases.
Affiliations and expertise
Whitehead Institute, Cambridge, MA, USA

JG

John Gurdon

Educated at Eton College, where he did Classics, having been advised he was unsuited for science. PhD with Michael Fischberg, on nuclear transplantation in Xenopus. Obtained the first clone of genetically identical adult animals. Demonstrated genetic totipotency of somatic cell nuclei by obtaining sexually mature frogs from the nuclei of intestinal epithelium. Postdoctoral work at Caltech, on bacteriophage genetics. Moved to MRC Molecular Biology Laboratory in Cambridge, subsequently becoming Head of Cell Biology Division. In 1983, accepted John Humphrey Plummer Professorship of Cell Biology in University of Cambridge, in Zoology Department. Initiated, with Prof R Laskey, Cancer Research Campaign unit of Molecular Embryology in Zoology Department Cambridge. In 1990 moved to new Wellcome CRC Institute of Cancer and Developmental Biology in Cambridge and served as Chairman 1990-2001. From 2001, the Institute was renamed The Gurdon Institute. Dr Gurdon has received multiple awards and recognitions internationally, too numerous to list.
Affiliations and expertise
The Wellcome Trust/ Cancer Research UK, Cambridge, UK

RL

Robert Lanza

Robert Lanza is an American scientist and author whose research spans the range of natural science, from biology to theoretical physics. TIME magazine recognized him as one of the “100 Most Influential People in the World,” and Prospect magazine named him one of the Top 50 “World Thinkers.” He has hundreds of scientific publications and over 30 books, including definitive references in the fields of stem cells, tissue engineering, and regenerative medicine. He’s a former Fulbright Scholar and studied with polio-pioneer Jonas Salk and Nobel laureates Gerald Edelman (known for his work on the biological basis of consciousness) and Rodney Porter. He also worked closely (and co-authored papers in Science on self-awareness and symbolic communication) with noted Harvard psychologist BF Skinner. Dr. Lanza was part of the team that cloned the world’s first human embryo, the first endangered species, and published the first-ever reports of pluripotent stem cell use in humans.
Affiliations and expertise
Astellas Institute for Regenerative Medicine, Westborough, MA, USA

MW

Michael West

Dr. Michael West is the Chief Executive Officer of AgeX Therapeutics, Inc. AgeX Therapeutics is focused on the development and commercialization of novel therapeutics targeting human aging. He received his Ph.D. from Baylor College of Medicine in 1989 concentrating on the biology of cellular aging. He has focused his academic and business career on the application of developmental biology to the age-related degenerative disease. He was the founder and first CEO of Geron Corporation of Menlo Park, California and from 1992 to 1998 he was a Director, and Vice President, where he initiated and managed programs in telomerase diagnostics, oligonucleotide-based telomerase inhibition as anti-tumor therapy, and the cloning and use of telomerase in telomerase-mediated therapy wherein telomerase is utilized to immortalize human cells.
Affiliations and expertise
BioTime Inc., Alameda, CA, USA

KC

Keith H.S. Campbell

Affiliations and expertise
The University of Nottingham, UK

View book on ScienceDirect

Read Principles of Cloning on ScienceDirect